Kiniksa Pharmaceuticals International Plc’s recently made public that its CHIEF OPERATING OFFICER Tessari Eben unloaded Company’s shares for reported $0.49 million on Jun 16 ’25. In the deal valued at $28.28 per share,17,300 shares were sold. As a result of this transaction, Tessari Eben now holds 61,563 shares worth roughly $1.7 million.
Then, Tessari Eben bought 17,300 shares, generating $489,171 in total proceeds.
Before that, Quart Barry D sold 12,336 shares. Kiniksa Pharmaceuticals International Plc shares valued at $374,891 were divested by the Director at a price of $30.39 per share. As a result of the transaction, Quart Barry D now holds 12,546 shares, worth roughly $0.35 million.
Citigroup initiated its Kiniksa Pharmaceuticals International Plc [KNSA] rating to a Buy in a research note published on March 13, 2025; the price target was $40. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Wells Fargo began covering KNSA with “an Overweight” recommendation on May 03, 2024. BofA Securities maintained its rating on June 29, 2020. It rated KNSA as “a Buy”.
Price Performance Review of KNSA
On Monday, Kiniksa Pharmaceuticals International Plc [NASDAQ:KNSA] saw its stock fall -1.32% to $27.67. Over the last five days, the stock has lost -3.66%. Kiniksa Pharmaceuticals International Plc shares have risen nearly 49.33% since the year began. Nevertheless, the stocks have risen 39.89% over the past one year. While a 52-week high of $30.69 was reached on 06/11/25, a 52-week low of $17.38 was recorded on 01/13/25.
Levels Of Support And Resistance For KNSA Stock
The 24-hour chart illustrates a support level at 26.99, which if violated will result in even more drops to 26.31. On the upside, there is a resistance level at 28.44. A further resistance level may holdings at 29.22.
How much short interest is there in Kiniksa Pharmaceuticals International Plc?
A steep rise in short interest was recorded in Kiniksa Pharmaceuticals International Plc stocks on 2025-06-13, dropping by -0.95 million shares to a total of 2.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.31 million shares. There was a decline of -40.13%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 01, 2020 when BofA/Merrill began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.
